Characterization and functionality of cell surface molecules on human mesenchymal stem cells

Journal of Biomedical Science

Volumn 10, Issue 2, 2003, Pages 228-241

  Majumdar, Manas K ^a   Keane Moore, Michele ^a   Buyaner, Diana ^a   Hardy, Wayne B ^a   Moorman, Mark A ^a   McIntosh, Kevin R ^a   Mosca, Joseph D ^a,b  

^a OSIRIS THERAPEUTICS INC   (United States)

^b Mymetics Corporation   (United States)

Author keywords

Antigen presentation; Hematopoietic interactions; Immune function; Mesenchymal stem cells; T lymphocytes

Indexed keywords

ALPHA1 INTEGRIN; ALPHA2 INTEGRIN; ALPHA3 INTEGRIN; ALPHA5 INTEGRIN; ALPHA6 INTEGRIN; ANTIGEN; BETA1 INTEGRIN; BETA3 INTEGRIN; BETA4 INTEGRIN; CD4 ANTIGEN; CD51 ANTIGEN; CD72 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; LIGAND; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; TETANUS TOXOID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; BINDING ASSAY; CELL FUNCTION; CELL ISOLATION; CELL LINE; CELL PROLIFERATION; CELL STIMULATION; CELL SURFACE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; EXPERIMENT; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MESENCHYME CELL; MOLECULE; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ROSETTE FORMATION; STEM CELL; T LYMPHOCYTE;

ADULT; ANTIGENS, CD8; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION; CELL DIVISION; CELL LINE; CELL LINE, TRANSFORMED; CELL LINEAGE; CELL MEMBRANE; CELL SEPARATION; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INTEGRINS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; LIGANDS; MESODERM; MIDDLE AGED; OLIGONUCLEOTIDES; PHENOTYPE; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS; T-LYMPHOCYTES;

EID: 0037221583     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1159/000068710     Document Type: Article

References (52)

1. Anderson G, Jenkinson EJ, Moore NC, Owen JJT. MHC class II-positive epithelium and mesenchyme cells are both required for T-cell development in the thymus. Nature 362:70-74;1993.
2. Beresfords JN. Osteogenic stem cell and the stromal system of bone and marrow. Clin Orthop 240:270-276;1989.
3. Bierer BE, Burakoff SJ. T cell receptors: Adhesion and signaling. Adv Cancer Res 56:49-54; 1991.
4. Bruder SP, Horwitz MC, Mosca JD, Haynes-worth SE. Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone 21:225-230;1997.
5. Bruder SP, Ricalton NS, Boynton RE, Connolly TJ, Jaiswal N, Zaia J, Barry FP. Mesenchymal stem cell surface antigen SB-10 corresponds to activated leukocyte cell adhesion molecule and is involved in osteogenic differentiation. J Bone Miner Res 13:655-660; 1998.
6. Caplan AI. Mesenchymal stem cells. J Orthop Res 9:641-646;1991.
7. Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature 367:425-429;1994.
8. Dempster DW, Moonga BS, Stein LS, Horbert WR, Antakly T. Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis. J Endocrinol 154:397-401; 1997.
9. Dorskind K. Regulation of hematopoiesis by bone marrow stromal cells and their products. Annu Rev Immunol 8:11-25;1990.
10. Epstein S. Mechanism of action of immunosuppressant agents producing bone loss: From basic research to clinical relevance. Bone and the Hematopoietic and Immune Systems Workshop, National Institutes of Health, Bethesda, 1997.
11. Felsenfeld DP, Choquet D, Sheetz MP. Ligand binding regulates the directed movement of beta-1 integrins on fibroblasts. Nature 383: 438-441;1996.
12. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124:619-625;1994.
13. Goelz S, Kumar R, Potvin B, Sundaram S, Brickelmaier M, Stanley P. Differential expression of an E-selectin ligand (Slex) by two Chinese hamster ovary cell lines transfected with the same alpha (1,3)-fucosyltransferase gene (ELFT). J Biol Chem 269:1033-1039;1994.
14. Gronthos S, Graves SE, Ohta S, Simmons PJ. The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood 84:4164-4169;1994.
15. Haraldsen G, Kvale D, Lien B, Farstad IN, Brandtzaeg P. Cytokine-regulated expression of E-selectin, intracellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human intestinal micro-vascular endothelial cells. J Immunol 156:2558-2563;1996.
16. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from the human marrow. Bone 13:81-87;1992.
17. Haynesworth SE, Baber MA, Caplan AI. Cyto-kine expression by human-derived mesenchymal progenitor cells in vitro: Effects of dexa-methasone and IL-1α. J Cell Physiol 166:585-591;1996.
18. Henseleit U, Steinbrink K, Sunderkotter C, Goebeler M, Roth J, Sorg C. Expression of murine VCAM-1 in vitro and in different models of inflammation in vivo: Correlation with emigration of monocytes. Exp Dermatol 3: 249-253;1994.
19. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11-20;1992.
20. Kansas GS. Selectins and their ligands: Current concepts and controversies. Blood 88:3259-3265;1996.
21. Kornberg LJ, Earp HS, Turner CE, Prockop C, Juliano RL. Signal transduction by integrins: Increased protein tyrosine phosphorylation caused by clustering of β1 integrins. Proc Natl Acad Sci USA 88:8392-8396;1991.
22. Lennon DP, Haynesworth SE, Bruder SP, Jaiswal N, Caplan AI. Development of a serum screen for mesenchymal progenitor cells from bone marrow. In Vitro Cell Dev Biol 32:602-607;1996.
23. Levesque J-P, Leavesley DI, Niutta S, Vadas M, Simmons PJ. Cytokines increase human hematopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med 181:1805-1809;1995.
24. Levesque J-P, Haylock DN, Simmons PJ. Cytokine regulation of proliferation and cell adhesion are correlated events in human CD34+ hematopoietic progenitors. Blood 88:1168-1174;1996.
25. Liesvield JL, Dipersio JF, Abboud CN. Integrin and adhesive receptors in normal and leukemic CD34+ progenitor cells: Potential regulatory checkpoint for cellular traffic. Leuk Lymphoma 14:19-24;1994.
26. Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF. Chondrogenic differentiation of human mesenchymal stem cells from marrow. Tissue Eng 4:415-420; 1998.
27. Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 176:57-63;1998.
28. Majumdar MK, Banks V, Peluso DP, Morris EA. Isolation, characterization, and chondrogenic potential of human bone marrow-derived multipotential stromal cells. J Cell Physiol 185:98-106;2000.
29. Matsuyama T, Yamada A, Kay J, Yamada KM, Akiyama SK, Schlossman SF, Morimoto C. Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex. J Exp Med 170:1133-1137;1989.
30. Meredith JE, Fazeli B, Schwartz MA. The extracellular matrix as a cell survival factor. Mol Biol Cell 4:953-959;1993.
31. Miyake K, Weissman IL, Greenberger JS, Kin-cade PW. Evidence for a role of the integrin VLA-4 in lympho-hematopoiesis. J Exp Med 173:599-605;1991
32. Morrison SJ, Shah NM, Anderson DJ. Regulatory mechanisms in stem cell biology. Cell 88: 287-293;1997.
33. Myers CL, Wertheimer SJ, Schembri-King J, Parks T, Wallace RW. Induction of ICAM-1 by TNF-α, IL-1β, and LPS in human endothelial cells after down-regulation of PKC. Am J Physiol 262:C767-771;1992.
34. Nojima Y, Humphries MJ, Mould AP, Komoriya P, Yamada KM, Schlossman SF, Morimoto C. VLA-4 mediates CD3-dependent CD4+ T cell activation via the CS1 alternatively spliced domain of fibronectin. J Exp Med 172:1185-1190;1990.
35. Pittenger MF, Mackay AM, Beck SC. Human mesenchymal stem cells can be directed into chondrocytes, adipocytes and osteocytes. Mol Biol Cell 7:305-309;1996.
36. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147;1999.
37. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-75;1997.
38. Sadahira Y, Yoshino T, Monobe Y. Very late activation antigen 4-vascular cell adhesion molecule 1 interaction is involved in the formation of erythroblastic islands. J Exp Med 181:411-416;1995.
39. Salomon DR, Crisa L, Mojcik CF, Ishii JK, Klier G, Shevach EM. Vascular cell adhesion molecule-1 is expressed by cortical thymic epithelial cells and mediates thymocyte adhesion. Implications for the function of α4β1 (VLA4) integrin in T-cell development. Blood 89: 2461-2466;1997.
40. Schwartz MA, Schaller MD, Ginsberg MH. Integrins: emerging paradigms of signal transduction. Ann Rev Cell Biol 11:549-555;1995.
41. Shimizu Y, Van Seventer GA, Horgan KJ, Shaw S. Regulated expression and binding of three VLA (beta 1) integrin receptors on T cells. Nature 345:250-254;1990.
42. Shimizu Y, Van Seventer GA, Horgan KJ, Shaw S. Roles of adhesion molecules in T cell recognition: Fundamental similarities between four integrins on resting human T cells (LFA-1, VLA-4, VLA-5, VLA-6) in expression, binding and costimulation. Immunol Rev 114:109-118;1990
43. Simmons PJ, Mesinosky B, Longenecker BM, Berenson R, Torok-Storb B, Gallatin WM. Vascular-cell adhesion molecule-1 expression by bone marrow stromal cells mediated the binding of hematopoietic progenitor cells. Blood 80:388-394;1992.
44. Springer TA. Adhesion receptors of the immune system. Nature 346:425-429;1990.
45. Stefansson S, Lawrence DA. The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature 383:441-444;1996.
46. Teixido J, Hemler ME, Greenberger JS, Ank-lessaria P. Role of β1 and β2 integrins in the adhesion of human CD34hi cells to bone marrow stroma. J Clin Invest 90:358-362;1993.
47. Thiede MA, Majumdar M, Mosca JD. Antibody-isolation of pluripotent human marrow stromal progenitor cells that support in vitro hematopoiesis by CD34+ bone marrow cells. Blood 88:186a;1996.
48. Tobias J, Chambers TJ. Glucocorticoids impair bone resorptive activity and viability of osteoclasts disaggregated from neonatal rat long bones. Endocrinology 125:1290-1295;1989.
49. Van Seventer GA, Newman W, Shimizu Y, Nutman TB, Tanaka Y, Horgan KJ, Gopal TV, Ennis E, O'Sullivan D, Grey H, Shaw S. Analysis of T cell stimulation by superantigen plus MHC class II molecules or by anti-CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1 but not ELAM-1. J Exp Med 174:901-907;1991.
50. Wahl SM, Allen JB, Weeks BS, Wong HL, Klotman PE. Transforming growth factor β enhances integrin expression and type IV collagenase secretion in human monocytes. Proc Natl Acad Sci USA 90:4577-4781;1993.
51. Wong D, Dorovini-Zis K. Expression of vascular cell adhesion molecule-1 (VCAM-1) by human brain microvessel endothelial cells in primary culture. Microvasc Res 49:325-330;1995.
52. Young RG, Butler DL, Weber W, Capan AI, Gordon SL, Fink DJ. Use of mesenchymal stem cell-in a collagen matrix for Achilles tendon repair. J Orthop Res 16:406-411;1998.